TAK-603, new rheumatic drug, inhibits rat mixed lymphocyte reactions and prolonges rat skin allograft survival.
Fujita
T
T
Division of Plastic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan. tfujita@sapmed.ac.jp
Ezoe
K
K
Matsumoto
Y
Y
Saito
T
T
Homma
K
K
Jimbow
K
K
Sato
N
N
D000818:Animals; D018501:Antirheumatic Agents / Q000494:pharmacology*; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D007959:Lymphocyte Culture Test, Mixed; D011804:Quinolines / Q000494:pharmacology*; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D016038:Skin Transplantation / Q000276:immunology*; D014184:Transplantation, Homologous / Q000276:immunology; D014230:Triazoles / Q000494:pharmacology*
D018501:Antirheumatic Agents; D011804:Quinolines; D014230:Triazoles; C104411:TAK 603